SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-21-006754
Filing Date
2021-03-02
Accepted
2021-03-01 20:12:48
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 nt10021058x1_s3.htm S-3 382848
2 EXHIBIT 4.4 nt10021058x1_ex4-4.htm EX-4.4 297279
3 EXHIBIT 4.5 nt10021058x1_ex4-5.htm EX-4.5 277837
4 EXHIBIT 5.1 nt10021058x1_ex5-1.htm EX-5.1 16910
5 EXHIBIT 23.1 nt10021058x1_ex23-1.htm EX-23.1 2320
6 logo_rocketpharma.jpg GRAPHIC 36798
  Complete submission text file 0001140361-21-006754.txt   1028800
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-253756 | Film No.: 21700679
SIC: 2834 Pharmaceutical Preparations